Education Program for Kidney Disease
(iPREP-RRT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is the Education Program for Kidney Disease safe for humans?
The available research does not provide specific safety data for the Education Program for Kidney Disease or its related programs like iPREP-RRT. However, the studies highlight the importance of patient safety in chronic kidney disease management, emphasizing the need for careful monitoring and communication to prevent adverse safety events.12345
How is the iPREP-RRT treatment different from other treatments for kidney disease?
The iPREP-RRT treatment is unique because it focuses on an intensive education and referral program, helping patients understand and choose the most suitable renal replacement therapy (RRT) for their condition, which can lead to better preparation and improved outcomes compared to standard treatments that may not emphasize patient education and involvement.678910
What data supports the effectiveness of the treatment Intensive Patient Referral and Education Program, iPREP-RRT?
Research shows that early patient referral to kidney specialists and education programs can lead to better preparation for kidney treatment and improved survival rates. Additionally, virtual education sessions have been effective in increasing patient access to necessary information, which can help them make informed decisions about their treatment options.3691112
Are You a Good Fit for This Trial?
This trial is for hospitalized African Americans with advanced chronic kidney disease (CKD). Participants should not have started renal replacement therapy. The program aims to educate and support them in managing their health, focusing on blood pressure control and CKD self-management.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Hospital-based Intervention
Participants receive education and self-management support during hospitalization
Community-based Intervention
Participants receive ongoing education and support through in-person sessions, phone calls, and text messages
Follow-up
Participants are monitored for knowledge, self-efficacy, and health intent after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Intensive Patient Referral and Education Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator